← Back to Patent Explorer
US4626549A Expired / Lapsed US ⏱️ 0.0 years remaining

Treatment of obesity with aryloxyphenylpropylamines

Assignee: Eli Lilly and Co
•
Filing: 1986-03-31
•
Granted: 1986-12-02
•
Expires: 2006-03-31
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract 3-Aryloxy-3-phenylpropylamines and acid addition salts thereof are useful in blocking uptake of monoamines by brain neurons, and are thus effective in treating disorders of sleep, sexual performance, appetite, muscular function, and pituitary function.

Inventors

  • 👤 Bryan B. Molloy
  • 👤 Klaus K. Schmiegel

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-11-04 01:43
CPC Classifications
A; A61; A61K; A61K31/00; A61K31/13; A61K31/135

Claims Analysis

Total Claims: 11
Claim 1
Independent Claim 81 words
A method of treating animals suffering from an appetite disorder comprising administering to said animal an effective amount of a compound of the formula ##STR7## wherein each R' is independently hydrogen or methyl; wherein R is naphthyl or ##STR8## wherein R" and R"' are halo, trifluoromethyl, C 1 -C 4 alkyl, C 1 -C 3 alkyloxy or C 3 -C 4 alkenyl; and wherein n and m are 0, 1 or 2; and acid addition salts thereof formed with pharmaceutically-acceptable acids.
Claim 2
Independent Claim 81 words
A method of treating animals suffering from an appetite disorder comprising administering to said animal an effective amount of a compound of the formula ##STR7## wherein each R' is independently hydrogen or methyl; wherein R is naphthyl or ##STR8## wherein R" and R"' are halo, trifluoromethyl, C 1 -C 4 alkyl, C 1 -C 3 alkyloxy or C 3 -C 4 alkenyl; and wherein n and m are 0, 1 or 2; and acid addition salts thereof formed with pharmaceutically-acceptable acids.
Claim 3
Dependent Claim 15 words
A method according to claim 1 employing N-methyl-3-(p-trifluoromethylphenoxy)-3-phenylpropylamine or a pharmaceutically-acceptable acid addition salt thereof.
Claim 4
Dependent Claim 8 words
The method of claim 2 employing N-methyl-3-(p-trifluoromethylphenoxy)-3-phenylpropylamine hydrochloride.
Claim 5
Independent Claim 85 words
A method of blocking the uptake of monoamines by brain neurons in animals comprising administering to said animal a monoamine blocking amount of a compound of the formula ##STR9## wherein each R' is independently hydrogen or methyl; wherein R is naphthyl or ##STR10## wherein R" and R"' are halo, trifluoromethyl, C 1 -C 4 alkyl, C 1 -C 3 alkyloxy or C 3 -C 4 alkenyl; and wherein n and m are 0, 1 or 2; and acid addition salts thereof formed with pharmaceutically-acceptable acids.
Claim 6
Independent Claim 85 words
A method of blocking the uptake of monoamines by brain neurons in animals comprising administering to said animal a monoamine blocking amount of a compound of the formula ##STR9## wherein each R' is independently hydrogen or methyl; wherein R is naphthyl or ##STR10## wherein R" and R"' are halo, trifluoromethyl, C 1 -C 4 alkyl, C 1 -C 3 alkyloxy or C 3 -C 4 alkenyl; and wherein n and m are 0, 1 or 2; and acid addition salts thereof formed with pharmaceutically-acceptable acids.
Claim 7
Dependent Claim 14 words
A method according to claim 4 wherein the monoamine to be blocked is serotonin.
Claim 8
Dependent Claim 15 words
A method according to claim 5 employing N-methyl-3-(p-trifluoromethylphenoxy)-3-phenylpropylamine or a pharmaceutically-acceptable acid addition salt thereof.
Claim 9
Dependent Claim 8 words
The method of claim 6 employing N-methyl-3-(p-trifluoromethylphenoxy)-3-phenylpropylamine hydrochloride.
Claim 10
Dependent Claim 14 words
The method of claim 5 employing N-methyl-3-(o-methylphenoxy)-3-phenylpropylamine or a pharmaceutically-acceptable acid addition salt thereof.
Claim 11
Dependent Claim 8 words
The method of claim 5 employing N-methyl-3-(o-methylphenoxy)-3-phenylpropylamine hydrochloride.

References Cited (Backward Citations)

US2683742A Cited
US3106564A Cited
US3132179A Cited
US3253040A Cited
US3562330A Cited
US4018895A Cited
US4194009A Cited
US4313896A Cited
US4314081A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1989-12-01 1990-06-02 1990-12-02 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1993-12-01 1994-06-02 1994-12-02 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1997-12-01 1998-06-02 1998-12-02 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag